Avicanna (AVCN) Q1 2025 earnings summary

Executive summary

• Achieved first profitable quarter in Q1 2025, marking a significant milestone for the company.

• Focused on scaling Canadian operations, international expansion, and advancing R&D pipeline.

Financial highlights

• Net income of $74,154 and comprehensive income of $876,092 in Q1 2025, driven by cost efficiencies and margin improvements.

• Adjusted positive EBITDA of ~$431,000, up from ~$18,000 in Q1 2024.

• Gross profit of $3.54 million, a 7% year-over-year increase; gross margins improved to 56% from 51%.

• Revenue of $6.32 million, a 2% decrease year-over-year; G&A expenses reduced by 5%.

Outlook and guidance

• Positioned to scale Canadian operations, pursue international expansion, and advance R&D and IP initiatives.

• Forward-looking statements highlight plans for business growth and ongoing product development.